{"id":749,"date":"2018-12-20T11:41:54","date_gmt":"2018-12-20T16:41:54","guid":{"rendered":"https:\/\/www.mesotheliomahope.com\/?page_id=749"},"modified":"2025-10-27T10:06:07","modified_gmt":"2025-10-27T14:06:07","slug":"clinical-trials","status":"publish","type":"page","link":"https:\/\/www.mesotheliomahope.com\/treatment\/clinical-trials\/","title":{"rendered":"Mesothelioma Clinical Trials"},"content":{"rendered":"<h2>What Are Clinical Trials for Mesothelioma?<\/h2>\n<p>Mesothelioma clinical trials are research studies that test <strong>new treatments, procedures, or combinations of therapies<\/strong> for this cancer.<\/p>\n<p>These trials are conducted at top cancer centers across the U.S. and are key in advancing medical knowledge and finding better ways to treat <a href=\"\/mesothelioma\/\">mesothelioma<\/a>.<\/p>\n<p>Participating in a clinical trial may open the door to new cancer treatments that could help you live longer and manage symptoms more effectively.<\/p>\n<blockquote><p>\u201cI\u2019ve been in five different clinical trials since I was diagnosed with peritoneal mesothelioma, a rare cancer that develops in the lining of the abdominal cavity. <strong>Each clinical trial has extended my life a bit longer<\/strong>.\u201d<br \/>\n\u2013 Dana, mesothelioma patient<\/p><\/blockquote>\n<h3>Types of Mesothelioma Clinical Trials<\/h3>\n<p>Clinical trials are designed with various goals in mind. Learn more about the most common types of mesothelioma clinical trials below.<\/p>\n<ul>\n<li><strong>Prevention trials<\/strong> explore new ways of keeping mesothelioma from developing or returning.<\/li>\n<li><strong>Screening trials<\/strong> focus on improving or developing methods to detect mesothelioma before <a href=\"\/mesothelioma\/symptoms\/\">symptoms<\/a> appear.<\/li>\n<li><strong>Diagnostic trials<\/strong> evaluate new tests to help detect mesothelioma earlier in patients who are already showing symptoms.<\/li>\n<li><strong>Treatment trials<\/strong> test innovative therapies and updated approaches to surgery, chemotherapy, and other standard treatments.<\/li>\n<li><strong>Quality-of-life trials<\/strong> aim to find better ways to manage mesothelioma symptoms and reduce treatment side effects.<\/li>\n<\/ul>\n<p>Mesothelioma Hope can match you with open clinical trials based on your diagnosis, location, and treatment goals \u2014 all at no cost to you.<\/p>\n<div id=\"28373\" class=\"one-off-28373 widget widget_oscar-vque one-off\" data-vqueid=\"28373\"><style type=\"text\/css\" data-style=\"one-off\">.entry-content .one-off-28373{margin:60px auto}.one-off-28373 a{background:#E4F4F6;border:1px solid #0FAEBF;border-radius:8px;color:#000;display:block;margin:0 auto;max-width:320px;overflow:hidden;padding:20px 20px 0;position:relative;text-decoration:none}.one-off-28373 a>div{display:block;display:flex;flex-direction:column}.one-off-28373 .vque-content,.one-off-28373 .image-wrap{z-index:1;position:relative}.one-off-28373 .vque-content{display:contents;z-index:2}.one-off-28373 .heading{order:1}.one-off-28373 .vque-content>img{max-width:220px;margin-bottom:20px}.one-off-28373 .vque-content p{order:4;background:#fff;margin:0 -20px;padding:15px;z-index:1}.one-off-28373 .image-wrap{left:50%;width:92%;z-index:1;transform:translateX(-50%);order:3;overflow:hidden}.one-off-28373 .image-wrap:after{content:'';background:#BADFE4;position:absolute;bottom:-128px;z-index:-1;width:216px;height:230px;border-radius:100%;left:50%;transform:translateX(-50%)}.one-off-28373 .image-wrap img{width:75%;margin:0 auto}.one-off-28373 .heading{font-size:24px;line-height:28px;display:block;max-width:340px;margin:0 0 25px;letter-spacing:-1px;max-width:270px}.one-off-28373 ul{list-style:none;margin-top:-10px;margin-left:0;text-align:left;font-size:16px;line-height:22px;margin-bottom:0;order:2}.one-off-28373 ul li{margin:0;position:relative;padding-left:30px;margin-bottom:10px}.one-off-28373 ul li::before{font-family:\"mesohope\"!important;speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;content:\"\\e904\";background:#0FAEBF;width:18px;height:18px;display:block;position:absolute;left:0;top:2px;border-radius:50%;color:#fff;font-size:9px;text-align:center;line-height:20px}.one-off-28373 .button{padding:12px 16px;width:100%;text-align:center}@media screen and (min-width:768px){.entry-content .one-off-28373 a{padding-right:0;padding-left:25px;max-width:620px}.entry-content .one-off-28373 .heading{padding-right:25px}.entry-content .one-off-28373 .vque-content{display:block;padding-bottom:35px;width:50%}.entry-content .one-off-28373 a>div{flex-direction:row;align-items:flex-end}.entry-content .one-off-28373 .vque-content p{margin:25px 0 0;background:none;padding:0}.entry-content .one-off-28373 .image-wrap{width:50%;left:auto;transform:none;overflow:visible}.entry-content .one-off-28373 .image-wrap img{width:125%;max-width:none}.entry-content .one-off-28373 .image-wrap:after{background:#0FAEBF;width:743px;height:597px;top:10px;left:-35px;transform:none}.entry-content .one-off-28373 .button{width:auto}.entry-content .one-off-28373 img{max-height:276px}.sidebar .one-off-28373{margin-bottom:30px}.sidebar .one-off-28373 img{max-height:125px}.sidebar .one-off-28373 .image-wrap:after{bottom:-135px}.sidebar .one-off-28373 .heading{font-size:22px}}<\/style><a href=\"\/clinical-trials\/\" title=\"Get Help Finding Clinical Trials\" class=\"cte\" data-ce-category=\"In-Content Ads\" data-ce-label=\"Get Help Finding Clinical Trials Ad\"><div>\r\n    <div class=\"vque-content\">\r\n        <strong class=\"heading\">Get Help Finding Clinical Trials<\/strong>\r\n        <ul>\r\n            <li>Match with trials that fit you<\/li>\r\n            <li>Get help enrolling for free<\/li>\r\n            <li>Access cutting-edge treatments<\/li>\r\n        <\/ul>\r\n        <p><strong class=\"button arrow\" title=\"Get Matched With Trials\">Get Matched With Trials<\/strong><\/p>\r\n    <\/div>\r\n    <div class=\"image-wrap\"><img decoding=\"async\"  src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"\/wp-content\/uploads\/2025\/06\/doctor-and-patient-3.png\" alt=\"Doctor with Patient\" class=\"lazyload mobile-only\" ><\/div>\r\n<\/div><\/a><\/div>\n<h2 id=\"list\">Find Mesothelioma Clinical Trials Near You<\/h2>\n<p>Use the dropdown menu below to find active mesothelioma clinical trials in your state.<\/p>\n<div class=\"clinical-trials-list\" id=\"clinicalTrials\"><strong>Active Mesothelioma Clinical Trials (52)<\/strong><span class=\"clinical-trial-state\">Show trials only in: <select id=\"trial-state\" name=\"trial-state\">\n        <option value=\"\" selected disabled>Select State<\/option>\n        <option value=\"Alabama\">Alabama<\/option>\n        <option value=\"Alaska\">Alaska<\/option>\n        <option value=\"Arizona\">Arizona<\/option>\n        <option value=\"Arkansas\">Arkansas<\/option>\n        <option value=\"California\">California<\/option>\n        <option value=\"Colorado\">Colorado<\/option>\n        <option value=\"Connecticut\">Connecticut<\/option>\n        <option value=\"Delaware\">Delaware<\/option>\n        <option value=\"District-of-Columbia\">District of Columbia<\/option>\n        <option value=\"Florida\">Florida<\/option>\n        <option value=\"Georgia\">Georgia<\/option>\n        <option value=\"Hawaii\">Hawaii<\/option>\n        <option value=\"Idaho\">Idaho<\/option>\n        <option value=\"Illinois\">Illinois<\/option>\n        <option value=\"Indiana\">Indiana<\/option>\n        <option value=\"Iowa\">Iowa<\/option>\n        <option value=\"Kansas\">Kansas<\/option>\n        <option value=\"Kentucky\">Kentucky<\/option>\n        <option value=\"Louisiana\">Louisiana<\/option>\n        <option value=\"Maine\">Maine<\/option>\n        <option value=\"Maryland\">Maryland<\/option>\n        <option value=\"Massachusetts\">Massachusetts<\/option>\n        <option value=\"Michigan\">Michigan<\/option>\n        <option value=\"Minnesota\">Minnesota<\/option>\n        <option value=\"Mississippi\">Mississippi<\/option>\n        <option value=\"Missouri\">Missouri<\/option>\n        <option value=\"Montana\">Montana<\/option>\n        <option value=\"Nebraska\">Nebraska<\/option>\n        <option value=\"Nevada\">Nevada<\/option>\n        <option value=\"New-Hampshire\">New Hampshire<\/option>\n        <option value=\"New-Jersey\">New Jersey<\/option>\n        <option value=\"New-Mexico\">New Mexico<\/option>\n        <option value=\"New-York\">New York<\/option>\n        <option value=\"North-Carolina\">North Carolina<\/option>\n        <option value=\"North-Dakota\">North Dakota<\/option>\n        <option value=\"Ohio\">Ohio<\/option>\n        <option value=\"Oklahoma\">Oklahoma<\/option>\n        <option value=\"Oregon\">Oregon<\/option>\n        <option value=\"Pennsylvania\">Pennsylvania<\/option>\n        <option value=\"Rhode-Island\">Rhode Island<\/option>\n        <option value=\"South-Carolina\">South Carolina<\/option>\n        <option value=\"South-Dakota\">South Dakota<\/option>\n        <option value=\"Tennessee\">Tennessee<\/option>\n        <option value=\"Texas\">Texas<\/option>\n        <option value=\"Utah\">Utah<\/option>\n        <option value=\"Vermont\">Vermont<\/option>\n        <option value=\"Virginia\">Virginia<\/option>\n        <option value=\"Washington\">Washington<\/option>\n        <option value=\"West-Virginia\">West Virginia<\/option>\n        <option value=\"Wisconsin\">Wisconsin<\/option>\n        <option value=\"Wyoming\">Wyoming<\/option>\n<\/select><\/span><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT03760575\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine<\/strong><\/div><div class=\"trial-location\">Location: Philadelphia, Pennsylvania<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT03760575\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesotheliomas Pleural from Abramson Cancer Center at Penn Medicine Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesotheliomas Pleural<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Pembrolizumab<\/li><li>Procedure: Indocyanine Green (ICG) Image-Guided Surgery<\/li><li>Drug: Cisplatin<\/li><li>Drug: Pemetrexed<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06710756\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Pancreatic Ductal Adenocarcinoma from Perspective Therapeutics\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Pancreatic Ductal Adenocarcinoma from Perspective Therapeutics<\/strong><\/div><div class=\"trial-location\">Location: St Louis, Missouri (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pancreatic Ductal Adenocarcinoma from Perspective Therapeutics\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06710756\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Pancreatic Ductal Adenocarcinoma from Perspective Therapeutics<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pancreatic Ductal Adenocarcinoma from Perspective Therapeutics Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase I\/IIa Image-Guided, Alpha-Particle Therapy Study of [203Pb]Pb-PSV359 and [212Pb]Pb-PSV359 in Patients With Solid Tumors That Are Known to be Fibroblast Activation Protein (FAP)-Positive<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: [203Pb]Pb-PSV359<\/li><li>Drug: [212Pb]Pb-PSV359<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Saint Louis University, St Louis, Missouri<\/li><li>Nebraska Cancer Specialists, Omaha, Nebraska<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05732831\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Locally Advanced Solid Tumor from Tango Therapeutics, Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.<\/strong><\/div><div class=\"trial-location\">Location: Palo Alto, California (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Locally Advanced Solid Tumor from Tango Therapeutics, Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05732831\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Locally Advanced Solid Tumor from Tango Therapeutics, Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Locally Advanced Solid Tumor from Tango Therapeutics, Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1\/2, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, and Preliminary Anti-tumor Activity of TNG462 as a Single Agent and in Combination in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: TNG462<\/li><li>Drug: Pembrolizumab<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Stanford University, Palo Alto, California<\/li><li>Grand Valley Oncology, Grand Junction, Colorado<\/li><li>Florida Cancer Specialists & Research Institute, Lake Mary, Florida<\/li><li>Sylvester Comprehensive Cancer Center, Miami, Florida<\/li><li>University Chicago Medicine, Chicago, Illinois<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06503146\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Sarcoma from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Sarcoma from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Sarcoma from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06503146\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Sarcoma from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Sarcoma from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: [18F]FAPI-74<\/li><li>Drug: [18F]FDG<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT01950572\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT01950572\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma and Other Mesothelin Expressing Cancers<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06477419\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from Memorial Sloan Kettering Cancer Center\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><\/div><div class=\"trial-location\">Location: Basking Ridge, New Jersey (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Memorial Sloan Kettering Cancer Center\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06477419\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Memorial Sloan Kettering Cancer Center Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase 2 Study of Sacituzumab Govitecan-hziy in Patients With Previously Treated Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><li>Mesotheliomas Pleural<\/li><li>Mesothelioma; Pleura<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Sacituzumab govitecan-hziy<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Memorial Sloan - Kettering Cancer Center, New York, New York<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT02012699\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Pancreatic Cancer from University of Nebraska\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Pancreatic Cancer from University of Nebraska<\/strong><\/div><div class=\"trial-location\">Location: Greenwood Village, Colorado (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pancreatic Cancer from University of Nebraska\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT02012699\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Pancreatic Cancer from University of Nebraska<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pancreatic Cancer from University of Nebraska Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Integrated Cancer Repository for Cancer Research<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Lung Cancer<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Advent Health, Greenwood Village, Colorado<\/li><li>Florida Hospital Memorial Medical Center, Daytona Beach, Florida<\/li><li>Florida Hospital DeLand, DeLand, Florida<\/li><li>Florida Hospital FISH, Orange City, Florida<\/li><li>Florida Hospital Flagler, Palm Coast, Florida<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05245500\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from Bristol-Myers Squibb\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from Bristol-Myers Squibb<\/strong><\/div><div class=\"trial-location\">Location: Phoenix, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Bristol-Myers Squibb\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05245500\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from Bristol-Myers Squibb<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Bristol-Myers Squibb Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1 Multiple Expansion Cohort Trial of MRTX1719 in Patients With Advanced Solid Tumors With Homozygous MTAP Deletion<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><li>Non Small Cell Lung Cancer<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: MRTX1719<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Mayo Clinic, Phoenix, Arizona<\/li><li>Sarah Cannon Research Institute (SCRI) - HealthONE Location, Denver, Colorado<\/li><li>Rocky Mountain Cancer Centers, LLP - Oncology, Lone Tree, Colorado<\/li><li>Mayo Clinic, Jacksonville, Florida<\/li><li>Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando, Florida<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06037941\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><\/div><div class=\"trial-location\">Location:  (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06037941\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Breathprinting (E-Nose) Technology to Measure Response to Treatment of Malignant Pleural Mesothelioma (MPM) Through MPM-Specific Volatile Organic Compounds Detected in Exhalates<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Malignant Pleural Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Diagnostic Test: E-Nose testing<\/li><li>Diagnostic Test: Research blood<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04897022\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><\/div><div class=\"trial-location\">Location:  (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04897022\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Pleural Mesothelioma from Memorial Sloan Kettering Cancer Center Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase I Dose Escalation and Local Control Study of Pembrolizumab + Intensity-Modulated Pleural Radiation Therapy (IMPRINT) for Malignant Pleural Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Malignant Pleural Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Pembrolizumab<\/li><li>Radiation: IMPRINT<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05703854\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center<\/strong><\/div><div class=\"trial-location\">Location: Houston, Texas<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05703854\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Renal Cell Carcinoma from M.D. Anderson Cancer Center Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase I\/II Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: CAR.70\/IL15-transduced CB-derived NK cells<\/li><li>Drug: Fludarabine phosphate<\/li><li>Drug: Cyclophosphamide<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>M D Anderson Cancer Center, Houston, Texas<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06466187\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Carcinoma, Non-Small-Cell Lung from Seagen Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Carcinoma, Non-Small-Cell Lung from Seagen Inc.<\/strong><\/div><div class=\"trial-location\">Location: Birmingham, Alabama (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Carcinoma, Non-Small-Cell Lung from Seagen Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06466187\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Carcinoma, Non-Small-Cell Lung from Seagen Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Carcinoma, Non-Small-Cell Lung from Seagen Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1 Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of SGN-MesoC2 in Subjects With Advanced Solid Tumors<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: PF-08052666<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>University of Alabama at Birmingham, Birmingham, Alabama<\/li><li>The University of Alabama at Birmingham, Birmingham, Alabama<\/li><li>University of Alabama at Birmingham, Birmingham, Alabama<\/li><li>The Board of Trustees of the University of Alabama for the University of Alabama at Birmingham, Birmingham, Alabama<\/li><li>Mayo Clinic Hospital, Phoenix, Arizona<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06452160\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from BridGene Biosciences Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from BridGene Biosciences Inc.<\/strong><\/div><div class=\"trial-location\">Location: Houston, Texas<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from BridGene Biosciences Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06452160\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from BridGene Biosciences Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from BridGene Biosciences Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BGC515 Capsules in Patients With Advanced Solid Tumors<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: BGC515<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>MD Anderson Cancer Center, Houston, Texas<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05873686\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Advanced Solid Tumor from Nuvectis Pharma, Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Advanced Solid Tumor from Nuvectis Pharma, Inc.<\/strong><\/div><div class=\"trial-location\">Location: Phoenix, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from Nuvectis Pharma, Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05873686\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Advanced Solid Tumor from Nuvectis Pharma, Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from Nuvectis Pharma, Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: NXP900<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Mayo Clinic, Phoenix, Arizona<\/li><li>Sarah Cannon Research Institute at HealthONE, Denver, Colorado<\/li><li>Mayo Clinic, Jacksonville, Florida<\/li><li>Oregon Health and Science University, Portland, Oregon<\/li><li>The University of Texas MD Anderson Cancer Center, Houston, Texas<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04665206\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Solid Tumor, Adult from Vivace Therapeutics, Inc\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc<\/strong><\/div><div class=\"trial-location\">Location: San Francisco, California (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from Vivace Therapeutics, Inc\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04665206\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Solid Tumor, Adult from Vivace Therapeutics, Inc<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from Vivace Therapeutics, Inc Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase I\/II, Multi-Center, Open-Label Study of VT3989, Alone or in Combination, in Patients With Locally Advanced or Metastatic Solid Tumors<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: VT3989<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California<\/li><li>University of Chicago Medical Center, Chicago, Illinois<\/li><li>Massachusetts General Hospital, Boston, Massachusetts<\/li><li>Dana-Farber Cancer Institute, Boston, Massachusetts<\/li><li>M Health Fairview University of Minnesota Medical Center, Minneapolis, Minnesota<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04115254\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Pancreas Cancer from Dana-Farber Cancer Institute\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Pancreas Cancer from Dana-Farber Cancer Institute<\/strong><\/div><div class=\"trial-location\">Location: Boston, Massachusetts (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pancreas Cancer from Dana-Farber Cancer Institute\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04115254\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Pancreas Cancer from Dana-Farber Cancer Institute<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pancreas Cancer from Dana-Farber Cancer Institute Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Master Protocol of Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy (SMART)<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Lung Cancer<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Radiation: MR-guided Linac<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Brigham & Women's Hospital, Boston, Massachusetts<\/li><li>Dana Farber Cancer Institute, Boston, Massachusetts<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05461430\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Pleural Effusion, Malignant from Travera Inc\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Pleural Effusion, Malignant from Travera Inc<\/strong><\/div><div class=\"trial-location\">Location: Oakland, California<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pleural Effusion, Malignant from Travera Inc\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05461430\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Pleural Effusion, Malignant from Travera Inc<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pleural Effusion, Malignant from Travera Inc Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Pleural Effusion, Malignant<\/li><li>Ascites, Malignant<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>xCures, Oakland, California<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04847063\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04847063\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Peritoneal Carcinomatosis from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Peritoneal Carcinomatosis<\/li><li>Peritoneal Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Procedure: Heated Intraperitonial Chemotherapy<\/li><li>Drug: Oxaliplatin<\/li><li>Drug: 5-Fluorouracil<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05647265\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology<\/strong><\/div><div class=\"trial-location\">Location: Anchorage, Alaska (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05647265\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pleural Biphasic Mesothelioma from Alliance for Clinical Trials in Oncology Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Official Title Neoadjuvant Immunotherapy in Sarcomatoid Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Pleural Biphasic Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Biological: Nivolumab<\/li><li>Biological: Ipilimumab<\/li><li>Procedure: Surgical Procedure<\/li><li>Procedure: Computed Tomography<\/li><li>Procedure: Magnetic Resonance Imaging<\/li><li>Procedure: Positron Emission Tomography<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Anchorage Associates in Radiation Medicine, Anchorage, Alaska<\/li><li>Anchorage Radiation Therapy Center, Anchorage, Alaska<\/li><li>Alaska Breast Care and Surgery LLC, Anchorage, Alaska<\/li><li>Alaska Oncology and Hematology LLC, Anchorage, Alaska<\/li><li>Alaska Women's Cancer Care, Anchorage, Alaska<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05627960\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Triple Negative Breast Cancer from A&G Pharmaceutical Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.<\/strong><\/div><div class=\"trial-location\">Location: Baltimore, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Triple Negative Breast Cancer from A&G Pharmaceutical Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05627960\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Triple Negative Breast Cancer from A&G Pharmaceutical Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Triple Negative Breast Cancer from A&G Pharmaceutical Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>FIH Phase 1A \/1B Study of AG01 Antibody Against Progranulin\/GP88 in Advanced Solid Tumor Malignancies With Expansion Cohorts in Advanced Triple Negative Breast Ca, Hormone Resistant Breast Ca, Non Small Cell Lung Cancer and Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Non Small Cell Lung Cancer<\/li><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: AG-01 Compound<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06756035\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelin-Expressing Tumors from Context Therapeutics Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelin-Expressing Tumors from Context Therapeutics Inc.<\/strong><\/div><div class=\"trial-location\">Location: Denver, Colorado (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelin-Expressing Tumors from Context Therapeutics Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06756035\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelin-Expressing Tumors from Context Therapeutics Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelin-Expressing Tumors from Context Therapeutics Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase 1a\/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: CT-95<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Context Investigational Site, Denver, Colorado<\/li><li>Context Investigational Site, Chicago, Illinois<\/li><li>Context Investigational Site, Grand Rapids, Michigan<\/li><li>Context Investigational Site, Hackensack, New Jersey<\/li><li>Context Investigational Site, Philadelphia, Pennsylvania<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06444815\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Solid Tumor, Adult from KaliVir Immunotherapeutics\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Solid Tumor, Adult from KaliVir Immunotherapeutics<\/strong><\/div><div class=\"trial-location\">Location: Los Angeles, California (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from KaliVir Immunotherapeutics\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06444815\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Solid Tumor, Adult from KaliVir Immunotherapeutics<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from KaliVir Immunotherapeutics Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1\/1b Study of VET3-TGI Administered Alone and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: VET3-TGI<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>USC\/Norris Comprehensive Cancer Center, Los Angeles, California<\/li><li>UC Irvine Health, Orange, California<\/li><li>University of Miami, Miami, Florida<\/li><li>Community Health Network, Indianapolis, Indiana<\/li><li>UPMC- Hillman Cancer Center, Pittsburgh, Pennsylvania<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06051695\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Solid Tumor, Adult from A2 Biotherapeutics Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.<\/strong><\/div><div class=\"trial-location\">Location: Gilbert, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from A2 Biotherapeutics Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06051695\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from A2 Biotherapeutics Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Seamless Phase 1\/2 Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Autologous Logic-gated Tmod\u2122 CAR T Products, in Heterozygous HLA-A*02 Adults With Recurrent Unresectable, Locally Advanced, or Metastatic Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Non Small Cell Lung Cancer<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Biological: A2B694<\/li><li>Diagnostic Test: xT CDx with HLA-LOH Assay<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Banner Health, Gilbert, Arizona<\/li><li>UCSD Moores Cancer Center, La Jolla, California<\/li><li>UCLA Medical Center, Los Angeles, California<\/li><li>Stanford University, Stanford, California<\/li><li>Mayo Clinic, Jacksonville, Florida<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT03683680\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from Dana-Farber Cancer Institute\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute<\/strong><\/div><div class=\"trial-location\">Location: Boston, Massachusetts<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Dana-Farber Cancer Institute\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT03683680\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from Dana-Farber Cancer Institute<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Dana-Farber Cancer Institute Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Other: MPT Test<\/li><li>Other: CLDN15\/VIM Test<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Brigham and Women's Hospital, Boston, Massachusetts<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06885697\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06885697\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase 1 Study With Dose Expansion of the Anti-Mesothelin TNaive\/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Device: mesothelin expression testing<\/li><li>Biological: TNhYP217 CAR T Cells<\/li><li>Drug: fludarabine<\/li><li>Drug: cyclophosphamide<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06251310\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Advanced Solid Tumor from SpringWorks Therapeutics, Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Advanced Solid Tumor from SpringWorks Therapeutics, Inc.<\/strong><\/div><div class=\"trial-location\">Location: Scottsdale, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from SpringWorks Therapeutics, Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06251310\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Advanced Solid Tumor from SpringWorks Therapeutics, Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from SpringWorks Therapeutics, Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1a\/1b Dose Escalation, Dose Expansion Study of SW-682 in Participants With Advanced Solid Tumors Enriched for Those With Hippo Pathway Mutations<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma, Malignant<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: SW-682<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>SpringWorks Clinical Trial Site, Scottsdale, Arizona<\/li><li>UC San Diego Moores Cancer Center, La Jolla, California<\/li><li>USC\/Norris Comprehensive Cancer Center, Los Angeles, California<\/li><li>SpringWorks Clinical Trial Site, Los Angeles, California<\/li><li>University Hospitals Cleveland Medical Center, Cleveland, Ohio<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05107674\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.<\/strong><\/div><div class=\"trial-location\">Location: Duarte, California (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05107674\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Ovarian Cancer, Epithelial from Nurix Therapeutics, Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1a, Dose Escalation, Safety and Tolerability Study of NX-1607, a Casitas B-lineage Lymphoma Proto-oncogene (CBL-B) Inhibitor, in Adults With Advanced Malignancies, With Phase 1b Expansion in Select Tumor Types<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: NX-1607<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>City of Hope, Duarte, California<\/li><li>University of Southern California, Los Angeles, California<\/li><li>University of California, San Francisco, San Francisco, California<\/li><li>University of Colorado School of Medicine, Aurora, Colorado<\/li><li>University of Chicago, Chicago, Illinois<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05544929\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Carcinoma, Non-Small-Cell Lung from Novartis\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Carcinoma, Non-Small-Cell Lung from Novartis<\/strong><\/div><div class=\"trial-location\">Location: Boston, Massachusetts (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Carcinoma, Non-Small-Cell Lung from Novartis\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05544929\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Carcinoma, Non-Small-Cell Lung from Novartis<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Carcinoma, Non-Small-Cell Lung from Novartis Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase I, Open-label, Multi-center Study of KFA115 as a Single Agent and in Combination With Pembrolizumab in Patients With Select Advanced Cancers<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: KFA115<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Massachusetts General Hospital ., Boston, Massachusetts<\/li><li>Massachusetts General Hospital, Boston, Massachusetts<\/li><li>NYU School of Medicine, New York, New York<\/li><li>University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania<\/li><li>SCRI Oncology Partners, Nashville, Tennessee<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT03830229\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT03830229\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05568680\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Ovarian Cancer from Verismo Therapeutics\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Ovarian Cancer from Verismo Therapeutics<\/strong><\/div><div class=\"trial-location\">Location: Westwood, Kansas (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Ovarian Cancer from Verismo Therapeutics\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05568680\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Ovarian Cancer from Verismo Therapeutics<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Ovarian Cancer from Verismo Therapeutics Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1 Study of SynKIR-110, Autologous T Cells Transduced With Mesothelin KIR-CAR, in Subjects With Mesothelin-Expressing Advanced Ovarian Cancer, Cholangiocarcinoma, or Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma, Malignant<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Biological: SynKIR-110, Autologous T cells Transduced with Mesothelin KIR-CAR<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>University of Kansas Cancer Center, Westwood, Kansas<\/li><li>University of Pennsylvania, Philadelphia, Pennsylvania<\/li><li>MD Anderson Cancer Center, Houston, Texas<\/li><li>University of Wisconsin Carbone Cancer Center, Madison, Wisconsin<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06362369\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Advanced Cancer from 7 Hills Pharma, LLC\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Advanced Cancer from 7 Hills Pharma, LLC<\/strong><\/div><div class=\"trial-location\">Location: Lake Mary, Florida (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Cancer from 7 Hills Pharma, LLC\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06362369\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Advanced Cancer from 7 Hills Pharma, LLC<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Cancer from 7 Hills Pharma, LLC Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1b\/2a Multi-Center, Dose Escalation and Reference Regimen-Controlled, Multi-Cohort Study to Determine the Safety and Efficacy of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy in Patients With Locally Advanced or Metastatic Cancers Following One or More Prior Therapies<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Pleural Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Alintegimod<\/li><li>Drug: Ipilimumab<\/li><li>Drug: Nivolumab<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Florida Cancer Specialists, Lake Mary, Florida<\/li><li>Dartmouth Hitchcock, Lebanon, New Hampshire<\/li><li>Brown University Health Cancer Institute, Providence, Rhode Island<\/li><li>MD Anderson Cancer Center, Houston, Texas<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04431024\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Familial Cancer from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Familial Cancer from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04431024\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Familial Cancer from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Familial Cancer from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05086692\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Advanced Solid Tumor from Medicenna Therapeutics, Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.<\/strong><\/div><div class=\"trial-location\">Location: San Diego, California (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from Medicenna Therapeutics, Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05086692\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Advanced Solid Tumor from Medicenna Therapeutics, Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from Medicenna Therapeutics, Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1\/2 Open Label, Dose Escalation and Expansion Study of MDNA11, IL-2 Superkine, Administered Alone or in Combination With Immune Checkpoint Inhibitor in Patients With Advanced Solid Tumors<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Non-Small Cell Lung Cancer Squamous<\/li><li>Non-Small Cell Lung Cancer Non-squamous<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: MDNA11<\/li><li>Drug: Pembrolizumab (KEYTRUDA\u00ae)<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Sharp Memorial Hospital, San Diego, California<\/li><li>UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California<\/li><li>Providence Saint John's Health Center, Santa Monica, California<\/li><li>Boca Raton Regional Hospital, Boca Raton, Florida<\/li><li>Emory - Winship Cancer Institute, Atlanta, Georgia<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05932199\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from Baylor College of Medicine\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from Baylor College of Medicine<\/strong><\/div><div class=\"trial-location\">Location: Durham, North Carolina (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Baylor College of Medicine\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05932199\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from Baylor College of Medicine<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Baylor College of Medicine Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Combination of Induction Durvalumab and Tremelimumab Alone Versus Durvalumab and Tremelimumab With Chemotherapy for Potentially Resectable Pleural Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Durvalumab \/ tremelimumab<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Duke Cancer Institute, Durham, North Carolina<\/li><li>Baylor St Lukes, Houston, Texas<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06057935\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><\/div><div class=\"trial-location\">Location: Chicago, Illinois (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06057935\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Peritoneal Mesothelioma from Memorial Sloan Kettering Cancer Center Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>ICARuS II (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multicenter, Randomized Phase II Trial of Normothermic Intraperitoneal Chemotherapy and Intravenous Chemotherapy After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Peritoneal Mesothelioma<\/li><li>Mesothelioma<\/li><li>Mesothelioma, Malignant<\/li><li>Malignant Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Pemetrexed<\/li><li>Drug: Cisplatin<\/li><li>Drug: Carboplatin<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>University of Chicago (Data Collection Only), Chicago, Illinois<\/li><li>University of Michigan (Data Collection Only), Ann Arbor, Michigan<\/li><li>Washington University (Data Collection Only), St Louis, Missouri<\/li><li>University of Nebraska (Data collection only), Omaha, Nebraska<\/li><li>Rutgers University (Data Collection Only), New Brunswick, New Jersey<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT00242723\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT00242723\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Pleural Mesotheliomas NOS from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Prospective Evaluation of Genetic and Epigenetic Alterations in Patients With Thoracic Malignancies<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Malignant Pleural Mesotheliomas NOS<\/li><li>Lung Cancer NOS<\/li><li>Thoracic Cancers<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04104776\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Advanced Solid Tumor from Novartis\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Advanced Solid Tumor from Novartis<\/strong><\/div><div class=\"trial-location\">Location: Atlanta, Georgia (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from Novartis\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04104776\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Advanced Solid Tumor from Novartis<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Advanced Solid Tumor from Novartis Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1\/2 Study of DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma, Malignant<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Tulmimetostat<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Winship Cancer Institute of Emory University, Atlanta, Georgia<\/li><li>University of Chicago Medical Center, Chicago, Illinois<\/li><li>University of Maryland - Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland<\/li><li>Massachusetts General Hospital, Boston, Massachusetts<\/li><li>Dana Farber Cancer Institute, Boston, Massachusetts<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT01416714\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Gastric Cancers from University of Chicago\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Gastric Cancers from University of Chicago<\/strong><\/div><div class=\"trial-location\">Location: Chicago, Illinois<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Gastric Cancers from University of Chicago\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT01416714\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Gastric Cancers from University of Chicago<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Gastric Cancers from University of Chicago Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy<\/p><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>The University of Chicago, Chicago, Illinois<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06538376\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Pulmonary Edema from Brigham and Women's Hospital\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Pulmonary Edema from Brigham and Women's Hospital<\/strong><\/div><div class=\"trial-location\">Location: Boston, Massachusetts<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pulmonary Edema from Brigham and Women's Hospital\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06538376\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Pulmonary Edema from Brigham and Women's Hospital<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Pulmonary Edema from Brigham and Women's Hospital Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Clinical Utility of Portable Dynamic Chest X-Ray (DDR) in the ICU: Clinical Trial to Demonstrate the Feasibility of Deploying DDR Technology in the ICU - A Study to Prove Its Increased Diagnostic Value<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Diagnostic Test: Portable Dynamic Digital Radiography (DDR)<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Brigham and Women's Hospital, Boston, Massachusetts<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05001880\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)<\/strong><\/div><div class=\"trial-location\">Location: Phoenix, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05001880\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Peritoneal Malignant Mesothelioma from National Cancer Institute (NCI) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase 2 Randomized Trial of Neoadjuvant or Palliative Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Peritoneal Malignant Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Biological: Atezolizumab<\/li><li>Biological: Bevacizumab<\/li><li>Procedure: Biospecimen Collection<\/li><li>Drug: Carboplatin<\/li><li>Procedure: Computed Tomography<\/li><li>Procedure: Cytoreductive Surgery<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Mayo Clinic Hospital in Arizona, Phoenix, Arizona<\/li><li>University of Chicago Comprehensive Cancer Center, Chicago, Illinois<\/li><li>Carle at The Riverfront, Danville, Illinois<\/li><li>Carle Physician Group-Effingham, Effingham, Illinois<\/li><li>Carle Physician Group-Mattoon\/Charleston, Mattoon, Illinois<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT01851395\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Thymus Tumors from National Institutes of Health Clinical Center (CC)\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)<\/strong><\/div><div class=\"trial-location\">Location: Bethesda, Maryland<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Thymus Tumors from National Institutes of Health Clinical Center (CC)\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT01851395\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Thymus Tumors from National Institutes of Health Clinical Center (CC)<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Thymus Tumors from National Institutes of Health Clinical Center (CC) Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Inpatient Hospice With Procurement of Tissue on Expiration in Thoracic Malignancies, Bladder Cancer, Ovarian Cancer, Epithelial Cancer and Patients Treated With an Adoptive Cellular Therapy<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><li>Lung Cancers<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>National Institutes of Health Clinical Center, Bethesda, Maryland<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT03007030\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center<\/strong><\/div><div class=\"trial-location\">Location: Houston, Texas<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT03007030\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on CD30-Positive Neoplastic Cells Present from M.D. Anderson Cancer Center Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase II Trial of Adcetris (Brentuximab Vedotin) in CD30+ Malignant Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Malignant Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Brentuximab Vedotin<\/li><li>Other: Laboratory Biomarker Analysis<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>M D Anderson Cancer Center, Houston, Texas<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT03556228\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Head and Neck Carcinoma from VM Oncology, LLC\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Head and Neck Carcinoma from VM Oncology, LLC<\/strong><\/div><div class=\"trial-location\">Location: Santa Rosa, California (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Head and Neck Carcinoma from VM Oncology, LLC\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT03556228\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Head and Neck Carcinoma from VM Oncology, LLC<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Head and Neck Carcinoma from VM Oncology, LLC Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1\/2 Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 as Monotherapy and in Combination With Pembrolizumab in Subjects With Solid Tumors or Lymphoma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Lung Cancer<\/li><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: VMD-928 100 mg Tablet<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Providence Medical Foundation (site 209), Santa Rosa, California<\/li><li>Hartford Hospital (site 210), Hartford, Connecticut<\/li><li>The George Washington University Cancer Center (site 212), Washington D.C., District of Columbia<\/li><li>Holy Cross Hospital (site 213), Fort Lauderdale, Florida<\/li><li>Memorial Cancer Institute at Memorial Healthcare Systems (site 132), Pembroke Pines, Florida<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT03420963\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center<\/strong><\/div><div class=\"trial-location\">Location: Houston, Texas<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT03420963\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Recurrent Cutaneous Melanoma from M.D. Anderson Cancer Center Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Ex-Vivo Expanded Allogeneic NK Cells for the Treatment of Solid Tumors of Pediatric Origin in Children and Young Adults<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Recurrent Malignant Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Biological: Cord Blood-derived Expanded Allogeneic Natural Killer Cells<\/li><li>Drug: Cyclophosphamide<\/li><li>Drug: Etoposide<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>M D Anderson Cancer Center, Houston, Texas<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05730816\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from Brigham and Women's Hospital\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from Brigham and Women's Hospital<\/strong><\/div><div class=\"trial-location\">Location: Boston, Massachusetts<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Brigham and Women's Hospital\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05730816\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from Brigham and Women's Hospital<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from Brigham and Women's Hospital Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>MAGIC-AKI: Magnesium for the Prevention of Hyperthermic Intraoperative Cisplatin-Associated AKI<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Magnesium sulfate<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Brigham and Women's Hospital, Boston, Massachusetts<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06097728\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Unresectable Pleural Mesothelioma from AstraZeneca\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Unresectable Pleural Mesothelioma from AstraZeneca<\/strong><\/div><div class=\"trial-location\">Location: Phoenix, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Unresectable Pleural Mesothelioma from AstraZeneca\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06097728\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Unresectable Pleural Mesothelioma from AstraZeneca<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Unresectable Pleural Mesothelioma from AstraZeneca Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma (eVOLVE-Meso)<\/p><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Volrustomig<\/li><li>Drug: Pemetrexed<\/li><li>Drug: Carboplatin<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Research Site, Phoenix, Arizona<\/li><li>Research Site, Duarte, California<\/li><li>Research Site, Santa Rosa, California<\/li><li>Research Site, Aurora, Colorado<\/li><li>Research Site, Jacksonville, Florida<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT05579366\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on High Grade Epithelial Ovarian Cancer from Genmab\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for High Grade Epithelial Ovarian Cancer from Genmab<\/strong><\/div><div class=\"trial-location\">Location: Phoenix, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on High Grade Epithelial Ovarian Cancer from Genmab\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT05579366\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for High Grade Epithelial Ovarian Cancer from Genmab<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on High Grade Epithelial Ovarian Cancer from Genmab Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase 1\/2 Study of Rina-S in Patients With Locally Advanced and\/or Metastatic Solid Tumors<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Primary Peritoneal Carcinoma<\/li><li>Non-small Cell Lung Cancer<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Rina-S<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>USOR HonorHealth, Phoenix, Arizona<\/li><li>USOR Arizona Oncology Associates, Tucson, Arizona<\/li><li>University of California Los Angeles Medical Center, Los Angeles, California<\/li><li>University of California, San Diego; Moores Cancer Center, San Diego, California<\/li><li>USOR Sansum Clinic, Santa Barbara, California<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04792463\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Uveal Melanoma from Ohio State University\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Uveal Melanoma from Ohio State University<\/strong><\/div><div class=\"trial-location\">Location: Columbus, Ohio<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Uveal Melanoma from Ohio State University\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04792463\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Uveal Melanoma from Ohio State University<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Uveal Melanoma from Ohio State University Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>BAP1 Gene Mutation<\/li><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>The Ohio State University Wexner Medical Center, Columbus, Ohio<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT06566079\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Malignant Mesothelioma from InSilico Medicine Hong Kong Limited\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Malignant Mesothelioma from InSilico Medicine Hong Kong Limited<\/strong><\/div><div class=\"trial-location\">Location: Denver, Colorado (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Mesothelioma from InSilico Medicine Hong Kong Limited\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT06566079\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Malignant Mesothelioma from InSilico Medicine Hong Kong Limited<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Malignant Mesothelioma from InSilico Medicine Hong Kong Limited Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 1, Open-Label, Multicenter, FIH Study to Evaluate the Safety, Tolerability, Pharmacokinetics\/Pharmacodynamics, and Preliminary Efficacy of ISM6331 in Participants With Advanced\/Metastatic Malignant Mesothelioma or Other Solid Tumors<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Malignant Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: ISM6331<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Sarah Cannon Research Institute at HealthONE, Denver, Colorado<\/li><li>The University of Chicago Medical Center - Duchossois Center for Advanced Medicine, Chicago, Illinois<\/li><li>University Hospitals Cleveland Medical Center, Cleveland, Ohio<\/li><li>University of Pennsylvania - Abramson Cancer Center, Philadelphia, Pennsylvania<\/li><li>SCRI Oncology Partners, Nashville, Tennessee<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT03935893\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Gastric Cancer from University of Pittsburgh\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Gastric Cancer from University of Pittsburgh<\/strong><\/div><div class=\"trial-location\">Location: Pittsburgh, Pennsylvania<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Gastric Cancer from University of Pittsburgh\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT03935893\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Gastric Cancer from University of Pittsburgh<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Gastric Cancer from University of Pittsburgh Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>A Phase 2 Study to Evaluate the Efficacy and Safety of Adoptive Transfer of Autologous Tumor Infiltrating Lymphocytes in Patients With Advanced Solid Cancers<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Biological: Tumor Infiltrating Lymphocytes (TIL)<\/li><li>Drug: Fludarabine + Cyclophosphamide combination<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04981119\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Solid Tumor, Adult from A2 Biotherapeutics Inc.\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.<\/strong><\/div><div class=\"trial-location\">Location: Gilbert, Arizona (multiple locations)<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from A2 Biotherapeutics Inc.\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04981119\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Solid Tumor, Adult from A2 Biotherapeutics Inc.<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Solid Tumor, Adult from A2 Biotherapeutics Inc. Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>An Observational Study Obtaining Solid Tumor Tissue From Participants and Apheresis for CAR T-Cell Therapy Manufacturing<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Non Small Cell Lung Cancer<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>Banner Health, Gilbert, Arizona<\/li><li>Mayo Clinic Hospital, Phoenix, Arizona<\/li><li>City of Hope, Duarte, California<\/li><li>University of California San Diego, La Jolla, California<\/li><li>Stanford University, Palo Alto, California<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><div class=\"clinical-trial-box row\"><div class=\"col-6\"><div class=\"trial-status\"><button \"type=\"button\" data-mfp-src=\"#recruiting-popup-NCT04515836\" class=\"popup-link-inline cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Recruiting on Mesothelioma from University of Chicago\">Recruiting<\/button><\/div><div class=\"trial-title\"><strong>Clinical Trial for Mesothelioma from University of Chicago<\/strong><\/div><div class=\"trial-location\">Location: Chicago, Illinois<\/div><div class=\"trial-subtitle\">Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from University of Chicago\">(866) 608-8933<\/a> to get help enrolling in this clinical trial<\/div><div id=\"recruiting-popup-NCT04515836\" class=\"white-popup mfp-hide\"><strong>Clinical Trial for Mesothelioma from University of Chicago<\/strong><p>Our Patient Advocates can help you connect with clinical trials<\/p><p>Call <a href=\"tel:+18666088933\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Phone Number on Mesothelioma from University of Chicago Popup\">(866) 608-8933<\/a> to get started<\/p><\/div><\/div><div class=\"col-6\"><p><strong>Trial Name<\/strong><br\/>Phase II Trial of Olaparib in Homologous Recombination Deficient (HRD) Malignant Mesothelioma<\/p><div class=\"trial-conditions\"><span><i class=\"icon-tumor\"><\/i><strong>Conditions<\/strong><\/span><ul><li>Mesothelioma<\/li><\/ul><\/div><div class=\"trial-interventions\"><span><i class=\"icon-medicine\"><\/i><strong>Interventions<\/strong><\/span><ul><li>Drug: Olaparib<\/li><\/ul><\/div><div class=\"trial-facility\"><span><i class=\"icon-globe\"><\/i><strong>Facility<\/strong><\/span><ul><li>University of Chicago Medical Center, Chicago, Illinois<\/li><\/ul><\/div><button class=\"show-more\">Show More<\/button><\/div><\/div><span class=\"pagination-wrap\"><span class=\"pagination\"><button class=\"prev\">Previous<\/button><button class=\"next\">Next<\/button><span class=\"pagination-counter\"><span class=\"page\"><\/span> of <span class=\"total-pages\"><\/span><\/span><\/span><\/span><span class=\"clinical-trial-disclaimer\"><strong>Don't see what you're looking for?<\/strong> <a href=\"\/about\/contact\/\" class=\"cte\" data-ce-category=\"Clinical Trials\" data-ce-label=\"Contact Us in Disclaimer\">Contact us<\/a> so one of our Patient Advocates can help you find the right clinical trial.<\/span><style type=\"text\/css\">.clinical-trials-list{margin:50px 0}.clinical-trials-list>strong{margin-bottom:20px;display:inline-block}.clinical-trials-list .clinical-trial-state{display:inline-block;margin-bottom:20px}.clinical-trials-list .pagination-wrap{text-align:center;display:block}.clinical-trials-list .pagination{margin:0 auto;list-style:none;display:inline-block;margin-bottom:20px;overflow:hidden;margin-top:25px}.clinical-trials-list .pagination button{color:#0FAEBF;display:inline-block;float:left;margin-right:15px;cursor:pointer;display:none;background-color:unset;border:none;box-shadow:none;padding:0}.clinical-trials-list .pagination button:last-child{margin-right:0}.clinical-trials-list .pagination button.next,.clinical-trials-list .pagination button.prev{display:block}.clinical-trials-list .pagination-counter{font-size:16px;font-style:italic;display:block;float:left;line-height:21px;color:#5B5B5B}.trial-page{display:none}.trial-page.current{display:block}.clinical-trial-box{background:#EDF8F9;border-radius:8px;border:1px solid #0FAEBF;font-size:17px;line-height:25px;padding:30px;margin:40px 0;position:relative}.clinical-trial-box>.col-6:last-child{background:#fff;border-radius:8px;padding:10px 20px 40px;max-height:215px;overflow:hidden;position:relative}.clinical-trial-box>.col-6:last-child.expand{max-height:none}.clinical-trial-box>.col-6:last-child.expand .show-more:before{background:none}.clinical-trial-box>.col-6:last-child.expand .show-more:after{transform:rotate(180deg)}.clinical-trial-box>.col-6:last-child span{display:block;display:flex;align-items:center;margin-bottom:5px}.clinical-trial-box>.col-6:last-child i{color:#0FAEBF;margin-right:10px;font-size:23px}.clinical-trial-box>.col-6:last-child ul{margin-left:50px;margin-bottom:10px}.clinical-trial-box>.col-6:last-child ul li{margin-bottom:0}.clinical-trial-box>.col-6:last-child ul li::marker{color:inherit;font-size:13px}.clinical-trial-box .show-more{background:#fff;list-style:none;padding:5px;text-align:center;display:block;color:#248AFF;position:absolute;border:none;border-radius:0;box-shadow:none;width:100%;font-weight:400;font-size:12px;line-height:25px;bottom:0;left:0;text-decoration:underline}.clinical-trial-box .show-more:after{content:\"\\e909\";font-family:\"mesohope\";font-size:11px;display:inline-block;vertical-align:middle;margin-left:8px;line-height:18px}.clinical-trial-box .show-more:before{content:\"\";display:block;background:linear-gradient(180deg, #fff 17.69%, rgba(255,255,255,0) 100%);transform:rotate(-180deg);height:50px;left:0;pointer-events:none;position:absolute;right:0;top:-50px;z-index:1}.clinical-trial-none{background:#EDF8F9;border-radius:8px;border:1px solid #0FAEBF;font-size:17px;line-height:25px;padding:30px;margin:0 0 40px;position:relative;text-align:center}.trial-status{display:inline-block;border:1px solid #008535;border-radius:4px;background:rgba(112,255,0,0.15);color:#008535;padding:5px 13px;margin-bottom:20px}.trial-status button{background-color:unset;color:unset;border:none;box-shadow:none;padding:unset}.trial-title{font-size:20px;line-height:29px}.trial-location{margin-bottom:20px}.mfp-inline-holder .mfp-content{max-width:460px}[id^=recruiting-popup]{max-width:460px;padding:25px;background-color:#F3F2F0;border:1px solid #C6C6C6;box-shadow:0px 4px 20px rgba(0,0,0,0.1);border-radius:8px}[id^=recruiting-popup] strong{margin-bottom:20px;display:block}[id^=recruiting-popup] p:nth-child(3){margin-bottom:0}[id^=recruiting-popup] .mfp-close{color:#100134 !important}.clinical-trial-disclaimer{display:block;text-align:center;font-size:17px;border-top:1px solid #0FAEBF;padding-top:30px}.clinical-trial-disclaimer strong{display:block}@media screen and (min-width: 1024px){.clinical-trials-list .clinical-trial-state{float:right}.clinical-trial-box>.col-6:first-child{padding:0 15px 0 0;margin-bottom:0}}<\/style><\/div>\n<h2>How Can Mesothelioma Clinical Trials Help Me?<\/h2>\n<p>Clinical trials for mesothelioma can provide more <a href=\"\/treatment\/\">treatment options<\/a> and give you hope if standard therapies aren&#8217;t working.<\/p>\n<p><strong>Mesothelioma clinical trials can also:<\/strong><\/p>\n<ul>\n<li>Allow you to receive care from <a href=\"\/treatment\/doctors\/\">top cancer specialists<\/a><\/li>\n<li>Potentially extend your life expectancy by months or even years<\/li>\n<li>Provide a chance for you to contribute to mesothelioma research<\/li>\n<\/ul>\n<p>Some treatments being tested in clinical studies may also help <strong>improve your quality of life<\/strong> by <a href=\"\/treatment\/pain-management\/\">reducing pain<\/a>, managing symptoms, or easing side effects from conventional therapies.<\/p>\n<div class=\"blockquote-w-image \"><img decoding=\"async\" src=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2022\/12\/dr-edward-levine.png\" alt=\"\" \/><blockquote><p>&#8220;Ongoing research trials are looking at different <a href=\"\/treatment\/immunotherapy\/\">immunotherapies<\/a> and targeted therapies, specifically for patients who harbor <strong>unusual mutations<\/strong> in the DNA of their particular tumor type.&#8221;<\/p>\n<footer>&ndash;<cite> Dr. Edward Levine, mesothelioma specialist at Atrium Health Wake Forest Baptist<\/cite><\/footer><\/blockquote><style type=\"text\/css\">.blockquote-w-image{position:relative;margin:40px auto}.blockquote-w-image blockquote{background:none;border-left:none;padding:25px;margin-top:0;padding-bottom:0;font-size:inherit;line-height:inherit}.blockquote-w-image blockquote footer cite{font-size:inherit}.blockquote-w-image blockquote p{margin-bottom:0}.blockquote-w-image img{width:100px;border:none;border-radius:100%;box-shadow:none;position:relative;margin:0 auto}.blockquote-w-image.alternative{margin:60px auto}.blockquote-w-image.alternative blockquote{padding:25px 25px 25px 80px;padding-bottom:25px;background-color:#E4F4F6}.blockquote-w-image.alternative img{position:absolute;left:20px;top:25px;z-index:1;width:50px;border:1px solid #fff;box-shadow:0 0 10px rgba(34,34,34,0.2);border-radius:100%}.blockquote-w-image.with-border{background:none;border-left:4px solid #0FAEBF}.blockquote-w-image.with-border blockquote{background:none;border-radius:0;padding:10px 25px}.blockquote-w-image.with-border blockquote footer cite{font-size:inherit}.blockquote-w-image blockquote:before{display:none}@media screen and (min-width: 769px){.blockquote-w-image img{position:absolute;left:0;top:0}.blockquote-w-image blockquote{padding:0 25px 0 125px;min-height:90px}}@media screen and (min-width: 1024px){.blockquote-w-image.alternative blockquote{padding-left:105px}.blockquote-w-image.alternative blockquote footer cite{font-size:16px}.entry-content .blockquote-w-image.alternative img{width:60px;left:25px}}<\/style><\/div>\n<h2>Emerging Treatments Being Tested in Mesothelioma Clinical Trials<\/h2>\n<p>Researchers continue to explore emerging treatments to help mesothelioma patients live longer and manage their symptoms more effectively. If a treatment shows promise in a clinical trial, it could become a standard therapy.<\/p>\n<p><strong>Treatments being tested in clinical trials include:<\/strong><\/p>\n<ul>\n<li><a href=\"\/treatment\/gene-therapy\/\"><strong>Gene therapy<\/strong><\/a><strong>:<\/strong> New genes are added to cancer cells to make them easier to attack.<\/li>\n<li><strong><a href=\"\/treatment\/immunotherapy\/mesothelioma-vaccine\/\">Mesothelioma vaccines<\/a>:<\/strong> Certain vaccines can help the immune system destroy mesothelioma cells.<\/li>\n<li><strong><a href=\"\/treatment\/photodynamic-therapy\/\">Photodynamic therapy<\/a>:<\/strong> A light-activated drug is injected into the body to kill cancer cells.<\/li>\n<li><strong><a href=\"\/treatment\/targeted-therapies\/\">Targeted therapies<\/a>:<\/strong> Specialized treatments attack mesothelioma cells without damaging the body\u2019s healthy cells.<\/li>\n<\/ul>\n<p>Use our <strong>Free Doctor Match service<\/strong> to connect with a specialist who can help you decide if a clinical trial is right for you.<\/p>\n<div id=\"25223\" class=\"one-off-25223 widget widget_oscar-vque one-off\" data-vqueid=\"25223\"><style type=\"text\/css\" data-style=\"one-off\">.one-off-25223{margin:60px auto}.one-off-25223 a{box-shadow:0 4px 4px 0 rgba(0,0,0,.25);display:block;background:#e4f4f6;padding:20px 25px 200px;text-decoration:none;color:inherit;position:relative;overflow:hidden;max-width:360px;margin:0 auto}.one-off-25223 a::before{background:#0FAEBF;border-radius:50% 50% 0 0;content:'';position:absolute;bottom:0;height:19%;width:135%;left:-60px;z-index:0}.one-off-25223 .vque-content,.one-off-25223 .image-wrap{z-index:1;position:relative}.one-off-25223 .image-wrap{width:100%;position:absolute;left:-10px;bottom:-15px}.one-off-25223 .image-wrap img{position:absolute;bottom:0;width:100%;max-width:unset;left:0}.one-off-25223 .heading{font-size:27px;line-height:33px;text-align:center;display:block;max-width:340px;margin:5px auto 25px}.one-off-25223 ul{list-style:none;margin:-10px auto 22px;text-align:left;font-size:16px;line-height:26px}.one-off-25223 ul li{margin:0 0 15px;position:relative;padding-left:35px}.one-off-25223 ul li::before{font-family:\"mesohope\"!important;speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;content:\"\\e904\";background:#0FAEBF;width:21px;height:21px;display:block;position:absolute;left:0;top:4px;border-radius:50%;color:#fff;font-size:11px;text-align:center;line-height:21px}.one-off-25223 p{text-align:center}.one-off-25223 .button{padding:12px 16px;display:block}@media screen and (min-width:768px){.one-off-25223 a{max-width:620px;padding:30px 30px 35px;border-radius:0 0 4px 4px}.one-off-25223 a::before{border-radius:50%;height:155%;width:150%;right:-550px;left:unset;bottom:-295px}.one-off-25223 .heading{text-align:left;margin:2px 0 25px;max-width:unset;font-size:24px}.one-off-25223 ul{margin:-7px 0 30px;max-width:365px;line-height:23px}.one-off-25223 ul li::before{top:1px}.one-off-25223 .image-wrap{max-width:unset;position:absolute;right:-25px;bottom:-35px;margin:0 0 -2px;left:unset;width:380px}.one-off-25223 .image-wrap img{position:relative;bottom:0;left:0;width:380px}.one-off-25223 .button{display:inline-block;padding:14px 25px}.one-off-25223 p{text-align:left}}@media screen and (min-width:1150px){.one-off-25223 a{padding:30px}}<\/style><a href=\"\/get-matched\/\" title=\"Get Matched With a Mesothelioma Doctor\" class=\"cte\" data-ce-category=\"In-Content Ads\" data-ce-label=\"Get Matched With a Mesothelioma Doctor Ad\"><div>\r\n    <div class=\"vque-content\">\r\n        <strong class=\"heading\">Get Matched With a Mesothelioma Doctor<\/strong>\r\n        <ul>\r\n            <li>Find top specialists near you<\/li>\r\n            <li>Seek compensation for travel & care<\/li>\r\n            <li>Get medical guidance<\/li>\r\n        <\/ul>\r\n        <p><strong class=\"button arrow\" title=\"Get Matched Now\">Get Matched Now<\/strong><\/p>\r\n    <\/div>\r\n    <div class=\"image-wrap\"><img decoding=\"async\"  src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" data-src=\"\/wp-content\/uploads\/2024\/07\/Doctors-ad.png\" alt=\"Get Matched With a Mesothelioma Doctor\" class=\"lazyload\" ><\/div>\r\n<\/div><\/a><\/div>\n<h2>Are Mesothelioma Clinical Trials Safe?<\/h2>\n<p><strong>Yes,<\/strong> clinical trials for mesothelioma are highly regulated by the FDA to protect patients\u2019 health and safety.<\/p>\n<p><strong>Key safety measures include:<\/strong><\/p>\n<ul>\n<li>Only enrolling patients after a treatment is proven safe in laboratory tests<\/li>\n<li>Providing a consent form to make sure patients understand any risks and potential side effects<\/li>\n<li>Requiring several phases of testing before opening trials to large groups of patients<\/li>\n<\/ul>\n<p><a href=\"\/cancer-centers\/\">Top mesothelioma cancer centers<\/a> also have safety protocols for clinical trials to reduce the risk of complications.<\/p>\n<p>If you join a mesothelioma clinical trial, you\u2019ll receive information about the potential benefits and drawbacks. <strong>You\u2019ll be given time to review these details before deciding whether to move forward.<\/strong><\/p>\n<div class=\"video-shortcode-container\"><style type=\"text\/css\">.video-shortcode-container{margin:40px 0;background:#F3F2F0;border-radius:15px;overflow:hidden;max-width:605px;font-size:16px}.video-shortcode-container:first-child{margin-top:0}.video-shortcode-container:last-child{margin-bottom:0}.video-shortcode-container>.youtube-video-place{background-size:cover;background-repeat:no-repeat;background-position:center;border:1px solid #fff;height:0;margin-bottom:0;padding-bottom:55.77%;position:relative}.video-shortcode-container>.youtube-video-place iframe{height:100%;left:0;position:absolute;top:0;width:100%}.video-shortcode-container>.youtube-video-place img{margin:0;width:100%}.video-shortcode-container>.youtube-video-place button[type=button]{background:none;border-radius:0 !important;box-shadow:none;border:none;height:100%;left:0;outline:0;position:absolute;top:0;transition:all 0.25s ease-in-out;width:100%}.video-shortcode-container>.youtube-video-place button[type=button]:before{font-family:\"mesohope\" !important;font-display:swap;speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;background:#F46E0F;border-radius:70px;color:#fff;content:\"\\e908\";display:block;font-size:50px;font-weight:bold;height:70px;left:50%;line-height:70px;position:absolute;text-indent:5px;top:50%;transform:translate(-50%, -50%);transition:all 0.25s ease-in-out;width:70px}.video-shortcode-container>.youtube-video-place button[type=button]:hover{background:rgba(255,255,255,0.1)}.video-shortcode-container>.youtube-video-place button[type=button]:hover:before{background:#2F293D;box-shadow:0 5px 20px #111;color:#fff}.video-shortcode-container .under-video-text{padding:20px 20px 25px}.video-shortcode-container .under-video-text>p:first-child{margin-bottom:0}.entry-content .video-shortcode-container .under-video-text a:not(.button),.entry-content .video-shortcode-container .under-video-text a:not(.button):visited{color:inherit}.entry-content .video-shortcode-container .under-video-text a:not(.button):hover,.entry-content .video-shortcode-container .under-video-text a:not(.button):visited:hover{color:#248AFF}.video-shortcode-container .under-video-text p.duration{margin:10px 0 0 0}.video-shortcode-container .under-video-text .show-more{color:#3344DD}.video-shortcode-container .under-video-text .show-more:hover{color:#248AFF}.video-shortcode-container .video-description-summary{color:#033E69;font-weight:bold}.video-shortcode-container .video-transcript{border:1px solid #E0E0E0;display:none;padding:20px;margin-top:20px;max-height:300px;overflow-y:scroll;border-radius:15px;background:#fff}.video-shortcode-container .video-transcript.show{display:block}.video-shortcode-container .video-transcript p{margin:0 0 15px}.video-shortcode-container .video-transcript p:last-child{margin:0}.video-shortcode-container .video-transcript::-webkit-scrollbar{width:13px}.video-shortcode-container .video-transcript::-webkit-scrollbar-track{background:none;box-shadow:none}.video-shortcode-container .video-transcript::-webkit-scrollbar-thumb{background-color:#ccc;border-radius:15px;border:1px solid #E0E0E0}.video-shortcode-container .see-more-videos{text-align:center;background:#0FAEBF;padding:10px;border-radius:0 0 15px 15px;color:#fff}.video-shortcode-container .see-more-videos a{color:#fff;font-weight:700;text-decoration:none;position:relative;display:block}.video-shortcode-container .see-more-videos a:after{content:\"\\e9ac\";font-family:\"mesohope\" !important;display:inline-block;vertical-align:middle;margin-left:10px;margin-top:-2px}.video-shortcode-container .see-more-videos a:hover{text-decoration:underline}.video-shortcode-container .what-next{display:none;background:#2E2E2EDB;color:#fff;padding:25px;margin-bottom:0;border-radius:8px 8px 0 0}.video-shortcode-container .what-next .header{font-size:18px;padding-bottom:30px;text-align:center;max-width:370px;margin:0 auto 30px;border-bottom:2px solid #0FAEBF;position:relative}.video-shortcode-container .what-next .header img{position:absolute;bottom:-17px;left:50%;transform:translateX(-50%);width:36px;height:36px;margin:0}.video-shortcode-container .what-next a{color:#fff;font-weight:700}.video-shortcode-container .what-next a:visited{color:#fff}.video-shortcode-container .what-next a:hover{text-decoration:none}.video-shortcode-container .what-next ol{list-style:decimal;margin-left:25px}.video-shortcode-container .what-next ol>li{margin-bottom:10px;padding-left:10px}.video-shortcode-container .what-next ol>li:before{display:none}.video-shortcode-container .what-next ol>li::marker{font-weight:700;color:#fff}@media screen and (min-width: 550px){.what-next{font-size:18px}.what-next .header{font-size:24px}}@media screen and (min-width: 768px){.what-next{padding:50px 40px}.what-next .header{padding-bottom:35px;margin-bottom:50px}.what-next ol{column-count:2}.what-next ol>li{margin-bottom:25px}}<\/style><script defer type=\"text\/javascript\" src=\"https:\/\/www.youtube.com\/iframe_api\"><\/script><div class=\"what-next\" data-video-name=\"Clinical Trials for Mesothelioma\">\n\t\t\t        \t<div class=\"header\">\n\t\t\t        \t\t<strong>What would you like to do now?<\/strong>\n\t\t\t        \t\t<img decoding=\"async\" src=\"\/wp-content\/uploads\/2024\/03\/MH-logo.png\" alt=\"Mesothelioma Hope Logo\" class=\"no-lazyload\" \/>\n\t\t\t        \t<\/div>\n\t\t\t        <\/div><div id=\"oscar-video-16264\" class=\"youtube-video-place embed-wrap-placeholder\"><img loading=\"lazy\" decoding=\"async\" alt=\"Clinical Trials for Mesothelioma Video Thumbnail\" data-src=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/10\/mesothelioma-clinical-trials-img-603x337.jpg\" class=\"attachment-full size-full lazyload\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" width=\"603\" height=\"337\"><noscript><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/10\/mesothelioma-clinical-trials-img-603x337.jpg\" alt=\"Clinical Trials for Mesothelioma Video Thumbnail\" class=\"attachment-full size-full\" width=\"603\" height=\"337\" \/><\/noscript><button type=\"button\" aria-label=\"Youtube Video\" class=\"embed-play\" data-youtube-url=\"https:\/\/www.youtube.com\/embed\/BKbcwaxmvgg\" data-embed-id=\"BKbcwaxmvgg\" data-video-category=\"treatment\" data-ce-category=\"Video\" data-ce-label=\"Play Button of Clinical Trials for Mesothelioma\"><span class=\"screen-reader-text\">Play Video<\/span><\/button><\/div><div class=\"under-video-text\"><p>Amy Fair, a nurse with over 20 years of mesothelioma experience, explains what clinical trials are, the types, and how to find them. Call our team at <a href='tel:+18666088933'>(866) 608-8933<\/a> to get matched with the best trial for your diagnosis. <a href=\"#\" data-collapsed=\"true\" title=\"Click to read Clinical Trials for Mesothelioma transcript \" class=\"show-more\" data-ce-category=\"Video\" data-ce-label=\"Read Transcript of Clinical Trials for Mesothelioma\">View Transcript.<\/a><\/p><p class=\"duration\">Duration: <strong>1 min 31 sec<\/strong><\/p><div class=\"video-transcript\"><p>Besides the standard treatment right now of radiation, surgery, and chemotherapy there are ongoing clinical trials at some facilities that some patients may fit.<\/p>\n<p>Clinical trials are the development of new and novel therapies.<\/p>\n<p>You have to be a candidate and meet certain criterial for clinical trials. Some trials evolve around a certain type of mesothelioma. Some evolve around a certain age group.<\/p>\n<p>There are exciting clinical trials out there now that involved immunotherapy, where they are strengthening and enhancing someone\u2019s immune system to fight the disease. There are target and gene therapies currently in clinical trials that target someone\u2019s DNA make up and molecular studies. These are still currently in several phases of clinical trials.<\/p>\n<p>If you are interested in a clinical trial or your oncologist thinks you\u2019re a candidate for a clinical trial the best way to learn is to start with your oncologist. They should be very knowledgeable about the clinical trials in your area. The National Institute of Health, on their website, has a tremendous amount of knowledge about clinical trials, the different phases that they are in and where these facilities are at that are involved in these clinical trials.<\/p>\n<\/div><\/div><div class=\"see-more-videos\"><a href=\"\/video-library\/?cat=treatment\" data-ce-category=\"Video\" data-ce-label=\"See More - Clinical Trials for Mesothelioma\">See More Treatment Videos<\/a><\/div><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@graph\": [{\"@type\": \"VideoObject\", \"name\": \"Clinical Trials for Mesothelioma\", \"uploadDate\": \"2021-04-07T00:00:00-04:00\", \"thumbnail\": \"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/10\/mesothelioma-clinical-trials-img.jpg\", \"thumbnailUrl\": \"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/10\/mesothelioma-clinical-trials-img.jpg\", \"embedUrl\": \"https:\/\/www.youtube.com\/embed\/BKbcwaxmvgg\", \"url\": \"https:\/\/www.youtube.com\/watch?v=BKbcwaxmvgg\", \"caption\": \"Amy Fair, a nurse with over 20 years of mesothelioma experience, explains what clinical trials are, the types, and how to find them. Call our team at &lt;a href='tel:+18666088933'&gt;(866) 608-8933&lt;\/a&gt; to get matched with the best trial for your diagnosis.\", \"description\": \"Amy Fair, a nurse with over 20 years of mesothelioma experience, explains what clinical trials are, the types, and how to find them. Call our team at &lt;a href='tel:+18666088933'&gt;(866) 608-8933&lt;\/a&gt; to get matched with the best trial for your diagnosis.\", \"transcript\": \"&lt;p&gt;Besides the standard treatment right now of radiation, surgery, and chemotherapy there are ongoing clinical trials at some facilities that some patients may fit.&lt;\/p&gt; &lt;p&gt;Clinical trials are the development of new and novel therapies.&lt;\/p&gt; &lt;p&gt;You have to be a candidate and meet certain criterial for clinical trials. Some trials evolve around a certain type of mesothelioma. Some evolve around a certain age group.&lt;\/p&gt; &lt;p&gt;There are exciting clinical trials out there now that involved immunotherapy, where they are strengthening and enhancing someone\u2019s immune system to fight the disease. There are target and gene therapies currently in clinical trials that target someone\u2019s DNA make up and molecular studies. These are still currently in several phases of clinical trials.&lt;\/p&gt; &lt;p&gt;If you are interested in a clinical trial or your oncologist thinks you\u2019re a candidate for a clinical trial the best way to learn is to start with your oncologist. They should be very knowledgeable about the clinical trials in your area. The National Institute of Health, on their website, has a tremendous amount of knowledge about clinical trials, the different phases that they are in and where these facilities are at that are involved in these clinical trials.&lt;\/p&gt; \",\"publisher\" : {\"@id\": \"https:\/\/www.mesotheliomahope.com\/#organization\"}}, {\"@type\": \"MediaObject\", \"thumbnailUrl\": \"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2020\/10\/mesothelioma-clinical-trials-img.jpg\", \"embedUrl\": \"https:\/\/www.youtube.com\/embed\/BKbcwaxmvgg\", \"uploadDate\": \"2021-04-07T00:00:00-04:00\", \"duration\": \"T01M31S\", \"startTime\": \"0:00\", \"endTime\": \"1:31\"}]}<\/script><\/div>\n<h2>Mesothelioma Clinical Trial Phases<\/h2>\n<p>Clinical trials for mesothelioma typically have multiple phases, each with a specific purpose. As the phases progress and safety is confirmed, the number of patients enrolled may increase.<\/p>\n<ul>\n<li><strong>Phase I trials<\/strong> are designed to find a safe dose of the new treatment, determine how it should be given, and learn how it affects the body. If a safe dose is found, the new treatment moves to phase II testing.<\/li>\n<li><strong>Phase II trials<\/strong> study how the treatment affects the body and how well it works for mesothelioma. If a new treatment is deemed safe and may help patients, it proceeds to phase III.<\/li>\n<li><strong>Phase III trials<\/strong> compare the new mesothelioma treatment with the current standard treatment to see which one is better. The results are submitted to the FDA for review.<\/li>\n<li><strong>Phase IV trials<\/strong> evaluate the long-term benefits and risks of the new treatment once it obtains FDA approval.<\/li>\n<\/ul>\n<p>Not all mesothelioma clinical trials go through all four phases. Some may combine phases (e.g., Phase I\/II or Phase II\/III) depending on the study\u2019s goals.<\/p>\n<h2>5 Questions to Ask Your Doctor About Mesothelioma Clinical Trials<\/h2>\n<p>Talking to your doctor can help you make an informed decision about whether or not to join a mesothelioma clinical trial. It\u2019s important to go into this conversation with specific questions in mind.<\/p>\n<p><strong>Here are 5 questions you can ask:<\/strong><\/p>\n<ol>\n<li>Has this treatment been used on other patients?<\/li>\n<li>What are the benefits and risks of participating in this trial?<\/li>\n<li>How might this study impact my daily life and current treatment plan?<\/li>\n<li>Where will I need to go to participate in this trial?<\/li>\n<li>What follow-up care does this clinical trial include?<\/li>\n<\/ol>\n<p>Use these questions to help ensure you leave your appointment with a clear understanding of how the trial may help you and whether it makes sense to move forward.<\/p>\n<p><strong>Download our Free Checklist<\/strong> for 14 more questions you should ask your doctor about your mesothelioma treatment plan.<\/p>\n<div data-vqueid=\"18575\" class=\"widget widget_oscar-vque outline image-left has-img\"><style type=\"text\/css\" data-style=\"outline\">.widget_oscar-vque.outline{margin:60px auto;max-width:315px}.widget_oscar-vque.outline:first-child{margin-top:0}.widget_oscar-vque.outline:last-child{margin-bottom:0}.widget_oscar-vque.outline>a{border:1px solid #E6E7EC;padding:20px;box-shadow:0 20px 20px rgba(34,34,34,0.03);border-radius:10px;color:#383441;display:block;text-decoration:none}.widget_oscar-vque.outline img{margin:0 auto 20px;max-width:180px}.widget_oscar-vque.outline .vque-content{color:#383441;font-size:16px;text-align:center}.widget_oscar-vque.outline strong.subheading{color:#100134;display:block;line-height:1;font-size:14px;margin-bottom:5px}.widget_oscar-vque.outline strong.heading{color:#100134;font-size:20px;display:block;margin:0 0 20px}.widget_oscar-vque.outline ul{font-size:16px;text-align:left;list-style:none;max-width:265px;margin:15px auto 25px}.widget_oscar-vque.outline ul li{padding-left:28px;margin-bottom:10px}.widget_oscar-vque.outline ul li:last-child{margin-bottom:0}.widget_oscar-vque.outline ul li:before{font-family:\"mesohope\" !important;font-display:swap;speak:none;color:#fff;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;content:\"\\e904\";border:none;position:absolute;left:0;top:3px;background:#0FAEBF;width:20px;height:20px;border-radius:20px;line-height:20px;text-align:center;font-size:12px}.widget_oscar-vque.outline strong.button.arrow{width:100%}.widget_oscar-vque.outline.image-left>a{position:relative;border-radius:0 10px 10px 0}.widget_oscar-vque.outline.image-left>a:before{content:\" \";position:absolute;top:0;bottom:0;width:4px;height:100%;left:0;background:linear-gradient(180deg, #0FAEBF 0%, #fff 100%)}@media screen and (min-width: 768px){.widget_oscar-vque.outline{max-width:620px}.widget_oscar-vque.outline img{max-width:100%}.widget_oscar-vque.outline>a{padding:0}.widget_oscar-vque.outline>a>div{display:block;display:flex;flex-wrap:wrap;align-items:flex-end;flex-direction:row-reverse}.widget_oscar-vque.outline>a>div>div{width:41%}.widget_oscar-vque.outline>a .vque-content{width:59%;padding:30px;text-align:left}.widget_oscar-vque.outline strong.subheading{font-size:16px}.widget_oscar-vque.outline strong.heading{font-size:24px;margin:0 0 13px}.widget_oscar-vque.outline ul{max-width:none}.widget_oscar-vque.outline strong.button.arrow{width:auto}.widget_oscar-vque.outline.image-left>a>div{display:block;position:relative;overflow:hidden}.widget_oscar-vque.outline.image-left>a>div>div{float:left}.widget_oscar-vque.outline.image-left>a>div>div:first-child{width:27%;padding:30px}.widget_oscar-vque.outline.image-left>a>div>div.vque-content{width:73%;padding-left:0;color:#383441}}<\/style><a href=\"\/doctor-questions\/\" title=\"Free Download: 14 Questions to Ask\u00a0Your Doctor\" class=\"cte\" data-ce-category=\"In-Content Ads\" data-ce-label=\"Free Download: 14 Questions to Ask\u00a0Your Doctor Ad\" data-desktop-image=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2021\/05\/questions-to-ask-doctor-ipad.png\"><div><div><img loading=\"lazy\" decoding=\"async\" width=\"95\" height=\"144\" src=\"https:\/\/www.mesotheliomahope.com\/wp-content\/uploads\/2021\/05\/questions-to-ask-doctor-ipad.png\" class=\"attachment-Medium size-Medium wp-post-image\" alt=\"14 Questions to Ask Your Doctor packet\" \/><\/div><div class=\"vque-content\"><strong class=\"heading\">Free Download: 14 Questions to Ask\u00a0Your Doctor<\/strong><ul>\n<li>Preparing for treatment<\/li>\n<li>Finding clinical trials<\/li>\n<li>Getting a second opinion<\/li>\n<\/ul>\n<p><strong class=\"button yellow arrow\" title=\"Get Your Free Download\">Get Your Free Download<\/strong><\/p><\/div><\/div><\/a><\/div>\n<h2>What to Expect After Joining a Mesothelioma Clinical Trial<\/h2>\n<p>Clinical trials can give you more options for treatment, but it helps to know what the process involves.<\/p>\n<ul>\n<li><strong>Randomized treatment:<\/strong> In some trials, you might be randomly assigned a standard treatment instead of the new treatment. You and your doctor won\u2019t be told which one you\u2019re getting to ensure the accuracy of the trial results.<\/li>\n<li><strong>Regular check-ups:<\/strong> You\u2019ll have routine visits where your doctor will monitor your progress and ask if you have any side effects.<\/li>\n<li><strong>Scans &amp; blood tests:<\/strong> Your doctor might order new <a href=\"\/mesothelioma\/diagnosis\/imaging-scans\/\">imaging scans<\/a> or blood tests to see how well the treatment is working.<\/li>\n<li><strong>Flexibility to withdraw:<\/strong> You can stop participating at any time, especially if you have serious side effects or if your cancer doesn\u2019t respond.<\/li>\n<li><strong>Follow-up care:<\/strong> After the trial ends, your doctor will evaluate you to see how your cancer responded to treatment.<\/li>\n<\/ul>\n<p>Participating in a clinical trial is a personal decision, and it\u2019s important to choose what feels right for you and your health.<\/p>\n<h2>Get Help Finding the Right Mesothelioma Clinical Trial<\/h2>\n<p>Mesothelioma clinical trials provide hope by giving you access to innovative treatments that may <strong>grant you more time with loved ones<\/strong>.<\/p>\n<p>However, finding and enrolling in clinical trials can be a confusing process, with multiple options, phases, and medical terms to decipher. That\u2019s where we step in to simplify the process.<\/p>\n<p><strong>Mesothelioma Hope is here to:<\/strong><\/p>\n<ul>\n<li>Connect you with top specialists for treatment<\/li>\n<li>Recommend clinical trials based on your diagnosis<\/li>\n<li>Guide you on how to manage any side effects<\/li>\n<\/ul>\n<p>Contact us today at <a href=\"tel:+18666088933\" title=\"Click to call (866) 608-8933\" class=\"in-content-tel-link\" data-ce-category=\"Click to Call\" data-ce-label=\"(866) 608-8933\">(866) 608-8933<\/a> or use our <a href=\"\/get-matched\/\">Free Doctor Match service<\/a> to get started.<\/p>\n<div class=\"faq-wrap\"><h2 class=\"faq-wrap-heading\">Clinical Trials for Mesothelioma FAQs<\/h2><div class=\"faq\" data-faq=\"1\"><h3 class=\"faq-heading\">Are there any new clinical trials for mesothelioma?<\/h3><div><p><strong>Yes<\/strong>, there are 56 active mesothelioma clinical trials in the U.S. as of September 2025.<\/p>\n<p>These include studies exploring combinations of chemotherapy and <strong>immunotherapy drugs<\/strong> like Keytruda\u00ae and Tecentriq\u00ae, as well as other emerging treatments such as <strong>gene therapy and targeted therapies<\/strong>.<\/p>\n<\/div><\/div><div class=\"faq\" data-faq=\"2\"><h3 class=\"faq-heading\">What is the new drug trial for mesothelioma?<\/h3><div><p>The <strong>ATOMIC-Meso<\/strong> clinical trial tests the new drug <a href=\"\/treatment\/chemotherapy\/pegargiminase\/\">pegargiminase (ADI-PEG20)<\/a> combined with traditional chemotherapy. ADI-PEG20 works by starving mesothelioma cells of the nutrients they need to grow.<\/p>\n<p><strong>The results so far are impressive:<\/strong> Combining ADI-PEG20 with chemotherapy <strong>quadrupled the <a href=\"\/mesothelioma\/prognosis\/survival-rate\/\">3-year survival rate<\/a><\/strong> compared to chemotherapy alone\u200b.<\/p>\n<\/div><\/div><div class=\"faq\" data-faq=\"3\"><h3 class=\"faq-heading\">Are there any active peritoneal mesothelioma clinical trials in 2026?<\/h3><div><p><strong>Yes.<\/strong> As of September 2025, there are 9 peritoneal mesothelioma clinical trials that are actively recruiting patients.<\/p>\n<p>One example is the Phase II ICARuS trial, which is studying whether patients with peritoneal mesothelioma can benefit from additional rounds of chemotherapy with pemetrexed and cisplatin after <a href=\"\/treatment\/surgery\/cytoreduction-hipec\/\">cytoreductive surgery with heated chemotherapy<\/a>.<\/p>\n<\/div><\/div><div class=\"faq\" data-faq=\"4\"><h3 class=\"faq-heading\">What are some recently completed mesothelioma clinical trials?<\/h3><div><p><strong>Mesothelioma clinical trials that were completed in the last year include:<\/strong><\/p>\n<ul>\n<li>A <strong>phase I\/II trial<\/strong> tested Gavo-cel, a type of immunotherapy designed to target mesothelin in mesothelioma cells. Several patients in the study had their cancer stabilize.<\/li>\n<li>A <strong>phase II clinical trial<\/strong> explored a targeted galinpepimut-S (GPS) vaccine. Data showed this combination helped mesothelioma patients live three times longer.<\/li>\n<li>The <strong>phase III ATOMIC-Meso trial<\/strong> combined a new drug, pegargiminase (ADI-PEG20), with traditional chemotherapy. This approach quadrupled survival at 36 months compared to chemotherapy alone.<\/li>\n<\/ul>\n<\/div><\/div><div class=\"faq\" data-faq=\"5\"><h3 class=\"faq-heading\">What is the wonder drug for mesothelioma?<\/h3><div><p>There is no single &#8220;wonder drug&#8221; for mesothelioma, but <strong>Keytruda (pembrolizumab) and Opdivo (nivolumab)<\/strong>, which are both immunotherapy drugs, have shown significant promise in helping mesothelioma patients live longer.<\/p>\n<\/div><\/div><div class=\"faq\" data-faq=\"6\"><h3 class=\"faq-heading\">Does it cost money to join clinical trials for mesothelioma?<\/h3><div><p><strong>No,<\/strong> it typically doesn\u2019t cost anything to join clinical trials for mesothelioma. Clinical trials are usually paid for by research institutions, pharmaceutical companies, or government agencies.<\/p>\n<p>However, depending on where the trial is located, you may need to pay for travel, transportation, or lodging.<\/p>\n<\/div><\/div><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\",\"@type\": \"FAQPage\",\"mainEntity\": [{\"@type\": \"Question\",\"name\": \"Are there any new clinical trials for mesothelioma?\",\"acceptedAnswer\":{\"@type\": \"Answer\",\"text\": \"&lt;p&gt;&lt;strong&gt;Yes&lt;\/strong&gt;, there are 56 active mesothelioma clinical trials in the U.S. as of September 2025.&lt;\/p&gt;\n&lt;p&gt;These include studies exploring combinations of chemotherapy and &lt;strong&gt;immunotherapy drugs&lt;\/strong&gt; like Keytruda\u00ae and Tecentriq\u00ae, as well as other emerging treatments such as &lt;strong&gt;gene therapy and targeted therapies&lt;\/strong&gt;.&lt;\/p&gt;\n\"}},{\"@type\": \"Question\",\"name\": \"What is the new drug trial for mesothelioma?\",\"acceptedAnswer\":{\"@type\": \"Answer\",\"text\": \"&lt;p&gt;The &lt;strong&gt;ATOMIC-Meso&lt;\/strong&gt; clinical trial tests the new drug pegargiminase (ADI-PEG20) combined with traditional chemotherapy. ADI-PEG20 works by starving mesothelioma cells of the nutrients they need to grow.&lt;\/p&gt;\n&lt;p&gt;&lt;strong&gt;The results so far are impressive:&lt;\/strong&gt; Combining ADI-PEG20 with chemotherapy &lt;strong&gt;quadrupled the 3-year survival rate&lt;\/strong&gt; compared to chemotherapy alone\u200b.&lt;\/p&gt;\n\"}},{\"@type\": \"Question\",\"name\": \"Are there any active peritoneal mesothelioma clinical trials in 2026?\",\"acceptedAnswer\":{\"@type\": \"Answer\",\"text\": \"&lt;p&gt;&lt;strong&gt;Yes.&lt;\/strong&gt; As of September 2025, there are 9 peritoneal mesothelioma clinical trials that are actively recruiting patients.&lt;\/p&gt;\n&lt;p&gt;One example is the Phase II ICARuS trial, which is studying whether patients with peritoneal mesothelioma can benefit from additional rounds of chemotherapy with pemetrexed and cisplatin after cytoreductive surgery with heated chemotherapy.&lt;\/p&gt;\n\"}},{\"@type\": \"Question\",\"name\": \"What are some recently completed mesothelioma clinical trials?\",\"acceptedAnswer\":{\"@type\": \"Answer\",\"text\": \"&lt;p&gt;&lt;strong&gt;Mesothelioma clinical trials that were completed in the last year include:&lt;\/strong&gt;&lt;\/p&gt;\n&lt;ul&gt;\n&lt;li&gt;A &lt;strong&gt;phase I\/II trial&lt;\/strong&gt; tested Gavo-cel, a type of immunotherapy designed to target mesothelin in mesothelioma cells. Several patients in the study had their cancer stabilize.&lt;\/li&gt;\n&lt;li&gt;A &lt;strong&gt;phase II clinical trial&lt;\/strong&gt; explored a targeted galinpepimut-S (GPS) vaccine. Data showed this combination helped mesothelioma patients live three times longer.&lt;\/li&gt;\n&lt;li&gt;The &lt;strong&gt;phase III ATOMIC-Meso trial&lt;\/strong&gt; combined a new drug, pegargiminase (ADI-PEG20), with traditional chemotherapy. This approach quadrupled survival at 36 months compared to chemotherapy alone.&lt;\/li&gt;\n&lt;\/ul&gt;\n\"}},{\"@type\": \"Question\",\"name\": \"What is the wonder drug for mesothelioma?\",\"acceptedAnswer\":{\"@type\": \"Answer\",\"text\": \"&lt;p&gt;There is no single &amp;#8220;wonder drug&amp;#8221; for mesothelioma, but &lt;strong&gt;Keytruda (pembrolizumab) and Opdivo (nivolumab)&lt;\/strong&gt;, which are both immunotherapy drugs, have shown significant promise in helping mesothelioma patients live longer.&lt;\/p&gt;\n\"}},{\"@type\": \"Question\",\"name\": \"Does it cost money to join clinical trials for mesothelioma?\",\"acceptedAnswer\":{\"@type\": \"Answer\",\"text\": \"&lt;p&gt;&lt;strong&gt;No,&lt;\/strong&gt; it typically doesn\u2019t cost anything to join clinical trials for mesothelioma. Clinical trials are usually paid for by research institutions, pharmaceutical companies, or government agencies.&lt;\/p&gt;\n&lt;p&gt;However, depending on where the trial is located, you may need to pay for travel, transportation, or lodging.&lt;\/p&gt;\n\"}}]}<\/script><style type=\"text\/css\">.faq-wrap{background:#E4F4F6;padding:20px 15px;margin:40px -15px}.faq-wrap:first-child{margin-top:0}.faq-wrap:last-child{margin-bottom:0}.faq-wrap .faq{background:#fff;padding:15px;border-radius:10px;box-shadow:0px 20px 20px rgba(0,0,0,0.03);margin:15px 0 0 0}.faq-wrap .faq:first-child{margin-top:0}.faq-wrap .faq .faq-heading{color:#100134;font-size:21px;margin-bottom:15px}.faq-wrap .faq p{margin-bottom:20px;line-height:1.5}.faq-wrap .faq p:last-child{margin-bottom:0}.faq-wrap .faq .learn-more{color:#248AFF;display:block;padding-right:17px;text-align:right;position:relative;line-height:1}.faq-wrap .faq .learn-more:visited{color:#248AFF}.faq-wrap .faq .learn-more:visited:hover,.faq-wrap .faq .learn-more:hover{color:#34d}.faq-wrap .faq .learn-more:after{font-family:\"mesohope\" !important;speak:none;font-style:normal;font-weight:normal;font-variant:normal;text-transform:none;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale;content:\"\\e905\";position:absolute;right:0;top:3px}h2.faq-wrap-heading{margin-bottom:25px}@media screen and (min-width: 768px){.faq-wrap{padding:25px 15px}}@media screen and (min-width: 1024px){.faq-wrap{border-radius:10px;margin-left:auto;margin-right:auto;padding:25px}.faq-wrap .faq{padding:25px}.faq-heading{font-size:24px}}<\/style><\/div>\n","protected":false},"excerpt":{"rendered":"<p>What Are Clinical Trials for Mesothelioma? Mesothelioma clinical trials are research studies that test new treatments, procedures, or combinations of therapies for this cancer. These trials are conducted at top cancer centers across the U.S. and are key in advancing medical knowledge and finding better ways to treat mesothelioma. Participating in a clinical trial may&hellip;<\/p>\n","protected":false},"author":49,"featured_media":1166,"parent":39,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-749","page","type-page","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages\/749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/users\/49"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/comments?post=749"}],"version-history":[{"count":0,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages\/749\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/pages\/39"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/media\/1166"}],"wp:attachment":[{"href":"https:\/\/www.mesotheliomahope.com\/wp-json\/wp\/v2\/media?parent=749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}